Search results for abx831358

Tezepelumab, Abbexa, abx831358

Tezepelumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TSLP, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Tezepelumab is under investigation in clinical trial NCT03406078 (Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma).